Exploratory Study of Signals for Asthma Drugs in Children, Using the EudraVigilance Database of Spontaneous Reports

Abstract

Introduction As asthma medications are frequently prescribed for children, knowledge of the safety of these drugs in the paediatric population is important. Although spontaneous reports cannot be used to prove causality of adverse events, they are important in the detection of safety signals. Objective Our objective was to provide an overview of adverse drug events associated with asthma medications in children from a spontaneous reports database and to identify new signals. Methods Spontaneous reports concerning asthma drugs were obtained from EudraVigilance, the European Medicine Agency's database for suspected adverse drug reactions. For each drug-event combination, we calculated the proportional reporting ratio (PRR) in the study period 2011-2017. Signals in children (aged 0-17 years) were compared with signals in the whole population. Analyses were repeated for different age categories, by sex and by therapeutic area. Results In total, 372,345 reports in children resulted in 385 different signals concerning asthma therapy. The largest group consisted of psychiatric events (65 signals). Only 30 signals were new, with seven, including herpes viral infections, associated with omalizumab. Stratification by age, sex and therapeutic area provided additional new signals, such as hypertrichoses with budesonide and encephalopathies with theophylline. Of all signals in children, 60 (16%) did not appear in the whole population. Conclusions The majority of signals regarding asthma therapy in children were already known, but we also identified new signals. We showed that signals can be masked if age stratification is not conducted. Further exploration is needed to investigate the risk and causality of the newly found signals.

Drug-induced Neuropsychiatric Adverse Events Using Post-Marketing Surveillance

“…These neuro- psychiatric symptoms included hyperactivity, hypersomnia and overnight phobia, and when the drug was discontinued, these adverse effects disappeared completely [ 23 ]. In the database of EudraVigilance, montelukast has been reported to be responsible for 2,210 psychotic adverse events in chil- dren with asthma [ 24 ]. In one case report, a 56-year-old man…”

Omalizumab is the Columbus egg for food allergies

“…We have had confirmation of this precisely with food allergy in recent years, when the ductility of the young child's immune system to allergenic exposure came to light [3,4]. In children over 6 years, some safety signals for Omalizumab were reported, including herpesvirus or bacterial infections and some visual disorders [5]. Patients with congenital absence of IgE may show chronic asthma, chronic sinusitis, otitis media, autoimmune, and oncological diseases [6,7].…”

Second-Generation Cephalosporins-Associated Drug-Induced Liver Disease: A Study in VigiBase with a Focus on the Elderly

“…Disproportionality analysis is the best approach to signal detection in pharmacovigilance [ 38 , 39 ]. The strength of drug-ADR dependency was defined by PRR, meaning the proportion of the event of interest (in our case hepatobiliary disorders) for a specific drug (in our case cephalosporins), compared to the proportion of the event of interest for all other drugs from the database [ 39 , 40 , 41 ]. Proportional Reporting Ratio values, with their 95% confidence intervals (CIs), were used as provided by the UMC.…”

“…Proportional Reporting Ratio values, with their 95% confidence intervals (CIs), were used as provided by the UMC. A lower value of the 95% confidence interval of the PRR >1 associated with ≥5 cases was considered a positive drug-ADR association [ 41 , 42 ].…”